NCT04226508 (CHOiCE) is a NA clinical trial of Physical exercise in Mixed Cancer, sponsored by Universita di Verona.

Who is sponsoring NCT04226508?

NCT04226508 is sponsored by Universita di Verona.

What drugs are being tested in NCT04226508?

Interventions in NCT04226508: Physical exercise.

What condition does NCT04226508 study?

NCT04226508 studies Mixed Cancer.

Is NCT04226508 still recruiting?

NCT04226508 is currently status unknown. Last updated 14 November 2023.

Last reviewed 2023-11-14 · How we verify

NCT04226508: CHOiCE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

"CHOiCE"! Choose Health: Oncological Patients Cenetered Exercise

Status unknown NA Last updated 14 November 2023

What this trial tests

NA trial testing Physical exercise in Mixed Cancer in 80 participants. Status unknown.

Timeline

1 September 2019

Primary endpoint
30 June 2023

30 July 2024

Quick facts

Lead sponsor	Universita di Verona
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	80
Start date	1 September 2019
Primary completion	30 June 2023
Estimated completion	30 July 2024
Sites	2 locations across Italy

Drugs / interventions tested

Physical exercise

Conditions studied

Mixed Cancer — all drugs for Mixed Cancer →

Sponsor

Universita di Verona — full company profile →

Who can join

Adults 18 to 90, any sex, with Mixed Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The "CHOICE!" study is an exercise program following the recommendation of the American College of Sports Science for cancer patients. The aims of the intervention are to test the safety and feasibility of a structured program, letting patients choose the modality of delivery. Secondary endpoints include exercise health-related skills and quality of life. The program considers the preferences of exercise of cancer survivors, giving the possibility to choose the exercise modality (autonomous, with a personal trainer or group class). This program will be tested in different cancer populations with different study designs based on different patients cohort (i.e., RCT or single-arm).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

A Feasibility Study Investigating an Exercise Program in Metastatic Cancer Based on the Patient-Preferred Delivery Mode.
Avancini A, Borsati A, Baldo E, Ciurnelli C, et al · · 2024 · cited 12× · PMID 38206849 · DOI 10.1093/oncolo/oyae002
Real-world feasibility and effectiveness of a personalized exercise program during cancer treatment: results from the CHOiCE prospective study.
Avancini A, Borsati A, Adamoli G, Toniolo L, et al · · 2026 · PMID 42015889 · DOI 10.1093/oncolo/oyag153

Verify or expand the search:

Other trials of Physical exercise

Trials testing the same drug.

NCT07397910 — Clinical Trial on a Natural Compound to Improve Chronic Inflammation After SARS-CoV-2 Infection · NA · not yet recruiting
NCT06952166 — Understanding the Psychological Benefits and Neurophysiological Mechanisms of Qigong in Older Adults · NA · not yet recruiting
NCT06846788 — Study of Nerve Injuries and Physical Exercise · NA · not yet recruiting
NCT04488159 — Immunoscore As Decision Guidance for Adjuvant Chemotherapy in Colon Cancer · Phase 3 · withdrawn
NCT06634316 — Sarcopenia in Patients With Heart Failure · NA · active not recruiting

Other Universita di Verona trials

Trials by the same sponsor.

NCT07393919 — Discontination of Antidepressants in Remitted Depression · Phase 4 · not yet recruiting
NCT07042724 — Exercise and Nutrition on Early-stage NSCLC Outcomes: the STARLighT Study · NA · recruiting
NCT07129954 — Fear of Falling in Muscular Dystrophy · NA · recruiting
NCT07119827 — Personality Traits as a Variable in the Recovery of Patients With Acquired Brain Injury · recruiting
NCT07209306 — WHO Psychological Interventions for Mental Health Outcomes in Migrants Resettled in Italy: the ADVANCE Trial · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04226508 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universita di Verona
Last refreshed: 14 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04226508.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing